PALI

Palisade Bio INC

-$62.9M

Net Activity

Institutions Holding

96

Popularity Rank

#4531

Avg Weight

0.30%

Total Value

$256.5M

Ownership Trend

96 institutions currently hold PALI, with 58 net buyers and 46 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

46

Net Buying Institutions

58

Key Holders

View all 96 holding institutions

Quarterly Activity

Recent Activity

+$164.3M

Total Buy Value

$154.1M

Total Sell Value

New buy29
Trim25
Add29
Sold out21

58

Net Buyers

46

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$411K

Total Est. Value

200K shares

Planned Shares

Last Filed 2026-07-07
FilerFiling DateEst. Value
Jones Mitchell Lawrence2026-07-07$108K
Finley John David2026-07-07$303K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding PALISADE BIO INC (PALI)?
Major stakeholders currently include B Group, Inc. ($20.0M), Janus Henderson Group PLC ($18.8M), Octagon Capital Advisors LP ($18.0M). Based on the latest 13F filings, there are a total of 96 tracked investment funds and institutions maintaining positions in PALI.
What is the overall institutional sentiment toward PALI recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $62.9M, driven by 58 managers accumulating shares while 46 reduced their exposure.
Which institutions have been selling or reducing their PALI positions?
In the latest period, 25 funds trimmed their holdings, and 21 managers completely exited their positions. The aggregate reported sell value was $154.1M.
Are there any notable investors adding PALI to their portfolios?
Yes, buying activity remains notable. 29 institutions opened new positions in {ticker}, and 29 existing holders added to their shares. The total reported buy value for the quarter amounted to $164.3M.

Related Stocks